SCHEMBL7790080

SCHEMBL7790080

Cc1cccc(C(=O)NC(CC(=O)O)c2cccc(NS(=O)(=O)c3cccc(NC(=N)N)c3)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
ITGB3 P05106 2/20 0.46
ITGA2B P08514 1/20 0.46
ALPL P05186 1/20 0.43
ALPI P09923 1/20 0.43
ALPG P10696 1/20 0.43
CYP26A1 O43174 1/20 0.43
PKM P14618 1/20 0.42
CTSA P10619 1/20 0.42
ITGAV P06756 1/20 0.41
MAPK1 P28482 1/20 0.41
THRB P10828 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7789975 0.92 ITGB3 (0.46) MEN1KMT2AITGB3ITGA2BPKM
SCHEMBL7194908 0.92 ITGB3 (0.51) MEN1KMT2AITGB3ITGA2BPKM
SCHEMBL7785609 0.90 LMNA (0.45) MEN1KMT2AITGB3ITGA2BPKM
SCHEMBL7786246 0.90 ITGB3 (0.46) MEN1KMT2AITGB3ITGA2BPKM
SCHEMBL7788290 0.88 ITGB3 (0.43) MEN1KMT2AITGB3ITGA2BCYP26A1
SCHEMBL7786217 0.87 KMT2A (0.46) MEN1KMT2AITGB3ITGA2BPKM
SCHEMBL7788754 0.87 ITGB3 (0.51) MEN1KMT2AITGB3ITGA2BPKM
SCHEMBL7790184 0.87 MEN1 (0.48) MEN1KMT2AITGB3ITGA2BITGAV
SCHEMBL7781212 0.87 ITGB3 (0.48) MEN1KMT2AITGB3ITGA2BITGAV
SCHEMBL7785662 0.86 MAPT (0.48) MEN1KMT2AITGB3ITGA2BMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed